Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei.

PLoS Negl Trop Dis

Netherlands Organization for Applied Scientific Research TNO, Department of CBRN Protection, Rijswijk, The Netherlands.

Published: January 2023

Background: Burkholderia mallei and Burkholderia pseudomallei are both potential biological threat agents. Melioidosis caused by B. pseudomallei is endemic in Southeast Asia and Northern Australia, while glanders caused by B. mallei infections are rare. Here we studied the proteomes of different B. mallei and B. pseudomallei isolates to determine species specific characteristics.

Methods: The expressed proteins of 5 B. mallei and 6 B. pseudomallei strains were characterized using liquid chromatography high-resolution tandem mass spectrometry (LC-HRMS/MS). Subsequently, expression of potential resistance and virulence related characteristics were analyzed and compared.

Results: Proteome analysis can be used for the identification of B. mallei and B. pseudomallei. Both species were identified based on >60 discriminative peptides. Expression of proteins potentially involved in antimicrobial resistance, AmrAB-OprA, BpeAB-OprB, BpeEF-OprC, PenA as well as several other efflux pump related proteins and putative β-lactamases was demonstrated. Despite, the fact that efflux pump BpeAB-OprB was expressed in all isolates, no clear correlation with an antimicrobial phenotype and the efflux-pump could be established. Also consistent with the phenotypes, no amino acid mutations in PenA known to result in β-lactam resistance could be identified. In all studied isolates, the expression of virulence (related) factors Capsule-1 and T2SS was demonstrated. The expression of T6SS-1 was demonstrated in all 6 B. pseudomallei isolates and in 2 of the 5 B. mallei isolates. In all, except one B. pseudomallei isolate, poly-beta-1,6 N-acetyl-D-glucosamine export porin (Pga), important for biofilm formation, was detected, which were absent in the proteomes of B. mallei. Siderophores, iron binding proteins, malleobactin and malleilactone are possibly expressed in both species under standard laboratory growth conditions. Expression of multiple proteins from both the malleobactin and malleilactone polyketide synthase (PKS) and non-ribosomal peptide synthetase (NRPS) clusters was demonstrated in both species. All B. pseudomallei expressed at least seven of the nine proteins of the bactobolin synthase cluster (bactobolin, is a ribosome targeting antibiotic), while only in one B. mallei isolate expression of two proteins of this synthase cluster was identified.

Conclusions: Analyzing the expressed proteomes revealed differences between B. mallei and B. pseudomallei but also between isolates from the same species. Proteome analysis can be used not only to identify B. mallei and B. pseudomallei but also to characterize the presence of important factors that putatively contribute to the pathogenesis of B. mallei and B. pseudomallei.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821509PMC
http://dx.doi.org/10.1371/journal.pntd.0011006DOI Listing

Publication Analysis

Top Keywords

mallei pseudomallei
24
mallei
12
pseudomallei
12
pseudomallei isolates
12
expression virulence
8
proteins
8
burkholderia mallei
8
mallei burkholderia
8
burkholderia pseudomallei
8
proteomes mallei
8

Similar Publications

Article Synopsis
  • Melioidosis is a severe tropical disease linked to the bacterium Burkholderia pseudomallei, which uses host cell mechanisms for mobility.
  • The study examined genetic variations of BimA and BimC in B. pseudomallei by analyzing 1,294 clinical isolates from northeast Thailand between 2015 and 2018.
  • Results showed conserved 3D structures of BimA and BimC variants across strains and confirmed their ability to form plaques and develop actin tails in host cells, providing insights into their role in bacterial virulence.
View Article and Find Full Text PDF

Virulome and phylogenomic profiling of a novel Burkholderia pseudomallei strain from an Indian clinical isolate.

Mol Genet Genomics

October 2024

Centre for Molecular Neurosciences, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.

Highly pathogenic Burkholderia pseudomallei is the causative agent of melioidosis, a neglected tropical disease endemic in Southeast Asian tropical region. This bacterium encompasses diverse virulence factors which further undergo dynamic gene-expression flux as it transits through distinct environmental niches within the host which may lead to manifestation of differential clinical symptoms. B.

View Article and Find Full Text PDF

Background/aim: Chemical biological radiological nuclear threats are at an important point in the agenda of world health today, as they can cause mass deaths. attracts attention as a potential biological warfare agent due to its features such as multidrug resistance, a rapid transmission mechanism via aerosol, the absence of a complete treatment protocol for the infection it causes, and the absence of an approved vaccine for protection against the bacteria. suspect samples must be studied by experienced personnel in biosafety level III laboratories.

View Article and Find Full Text PDF

Background: Melioidosis is a bacterial infection associated with high mortality. The diagnostic approach to this rare disease in Europe is challenging, especially because pulmonary manifestation of melioidosis can mimic pulmonary tuberculosis (TB). Antibiotic therapy of melioidosis consists of an initial intensive phase of 2-8 weeks followed by an eradication therapy of 3-6 months.

View Article and Find Full Text PDF
Article Synopsis
  • Bpc species are Gram-negative bacteria causing diseases like melioidosis and glanders, with recent advances in vaccine development focusing on subunit and glycoconjugate vaccines.
  • The Bcc species, a second group of pathogenic bacteria, mainly affects those with weakened immune systems and has limited vaccine development efforts.
  • This review aims to evaluate the protective efficacy of various Bpc antigens, their study limitations, and whether these antigens could be used in a broader vaccine to protect against both Bpc and Bcc bacterial infections.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!